Place of death among individuals with chronic respiratory diseases in China: Trends and associated factors between 2014 and 2020 by Xunliang Tong, Wei Wang, Xinyue Zhang, Peng Yin, Enying Gong, Yanming Li, Maigeng Zhou

Get full text

Aspergillus fumigatus during COPD exacerbation: a pair-matched retrospective study by Xunliang Tong, Anqi Cheng, Hongtao Xu, Jin Jin, Yimeng Yang, Sainan Zhu, Yanming Li

Get full text

Non‐pharmacological interventions for asthma prevention and management across the life course: Umbrella review by Xunliang Tong, Xinyue Zhang, Mengyuan Wang, Zijun Wang, Fawu Dong, Enying Gong, Torsten Zuberbier, Yanming Li

Get full text

Clinical characteristics and outcome of influenza virus infection among adults hospitalized with severe COVID-19: a retrospective cohort study from Wuhan, China by Xunliang Tong, Xiaomao Xu, Guoyue Lv, He Wang, Anqi Cheng, Dingyi Wang, Guohui Fan, Yue Zhang, Yanming Li

Get full text

Risk factors associated with functional decline in older hospital survivors with acute lower respiratory tract infections: a prospective cohort study by Bingxuan Weng, Jin Jin, Lixue Huang, Xunliang Tong, Wenshu Jiao, Yuanqi Wang, Chuangsen Fang, Mengyuan Wang, Yanming Li

Get full text

Association between ambient sulfur dioxide pollution and asthma mortality: Evidence from a nationwide analysis in China by Wei Liu, Miao Cai, Zheng Long, Xunliang Tong, Yanming Li, Lijun Wang, Maigeng Zhou, Jing Wei, Hualiang Lin, Peng Yin

Get full text

Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma: A case series by Lixue Huang, Xunliang Tong, Jia Cui, Xiaoman Du, Yixuan Liao, Xiaoming Tan, Yang Ju, Xuefeng Zhong, Wei Zhou, Xiaomao Xu, Yanming Li

Get full text

Factors Predicting Progression to Severe COVID-19: A Competing Risk Survival Analysis of 1753 Patients in Community Isolation in Wuhan, China by Simiao Chen, Hui Sun, Mei Heng, Xunliang Tong, Pascal Geldsetzer, Zhuoran Wang, Peixin Wu, Juntao Yang, Yu Hu, Chen Wang, Till Bärnighausen

Get full text

Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma by Georg Bölke, MD, Xunliang Tong, MD, Torsten Zuberbier, MD, PhD, Jean Bousquet, MD, PhD, Karl-Christian Bergmann, MD, PhD

Get full text

Metagenomic Human Repiratory Air in a Hospital Environment. by Yi Yu Lai, Yanming Li, Jidong Lang, Xunliang Tong, Lina Zhang, Jianhuo Fang, Jingli Xing, Meng Cai, Hongtao Xu, Yan Deng, Fei Xiao, Geng Tian

Get full text

Concomitant Medication Use With Xiyanping Injection and the Risk of Suspected Allergic Reactions: A Nested Case–Control Study Based on China’s National Medical Insurance Database... by Xunliang Tong, Xiaochen Zhu, Xiaochen Zhu, Chunping Wang, Chunping Wang, Yifan Zhou, Yingying Yan, Siyan Zhan, He Zhu, He Zhu, Sheng Han, Sheng Han, Yinchu Cheng

Get full text

Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA by Xunliang Tong, Xiaowei Yu, Yang Du, Fei Su, Ye Liu, Hexin Li, Yunshan Liu, Kai Mu, Qingsong Liu, Hui Li, Jiansheng Zhu, Hongtao Xu, Fei Xiao, Yanming Li

Get full text

Spatial, temporal and demographic patterns in asthma mortality in China: A systematic analysis from 2014 to 2020 by Xunliang Tong, MD, Peng Yin, PhD, Wei Liu, BMed, Simiao Chen, PhD, Pascal Geldsetzer, PhD, Zheng Long, PhD, Anqi Cheng, MD, Maigeng Zhou, PhD, Yanming Li, MD

Get full text

Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome by Xiaoman Du, MD, Yudi Chen, MD, Jianmin Chang, MD, Xuelin Sun, MD, PhD, Yue Zhang, MS, Meng Zhang, BM, Marcus Maurer, MD, PhD, Yanming Li, MD, Zuotao Zhao, MD, PhD, Xunliang Tong, MD, PhD

Get full text

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients by Xunliang Tong, Fei Su, Xiaomao Xu, Hongtao Xu, Ting Yang, Ting Yang, Qixia Xu, Huaping Dai, Huaping Dai, Kewu Huang, Lihui Zou, Wenna Zhang, Surui Pei, Fei Xiao, Fei Xiao, Yanming Li, Chen Wang, Chen Wang, Chen Wang

Get full text

Expert consensus on the use of omalizumab in chronic urticaria in China by Zuotao Zhao, MD, PhD, Tao Cai, MD, Hong Chen, MD, Liuqing Chen, MD, Yudi Chen, MD, Xiang Gao, MD, Xinghua Gao, MD, Songmei Geng, MD, Yinshi Guo, MD, Fei Hao, MD, Guodong Hao, MM, Yan Hu, MD, Hongzhong Jin, MD, Zhehu Jin, MD, Chengxin Li, MD, Haili Li, MD, Jie Li, MD, Yanming Li, MD, Yunsheng Liang, MD, Guanghui Liu, MD, Qiang Liu, MD, Hai Long, MD, Lin Ma, MD, Yuanyuan Shang, MM, Yuxin Song, MB, Zhiqiang Song, MD, Xiangyang Su, MD, Haijing Sui, MD, Qing Sun, MD, Yuemei Sun, MB, Jianping Tang, MD, Xunliang Tong, MD, Huiying Wang, MD, Gang Wang, MD, Lianglu Wang, MD, Siqin Wang, MB, Li Xiang, MD, Ting Xiao, MD, Zhiqiang Xie, MD., Leping Ye, MD, Yongmei Yu, MM, Chunlei Zhang, MD, PhD, Litao Zhang, MD, Shuchen Zhang, MD, PhD, Rui Zheng, MD, Lili Zhi, MM, Wei Zhou, MD, Ying Zou, MD, Marcus Maurer, MD

Get full text